The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

24 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Specific inhibition of HIV-1 protease by boronated porphyrins.EBI
University Of California
Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors.EBI
Parke-Davis Pharmaceutical Research Division Of Warner-Lambert
Design of rat renin inhibitory peptides.EBI
Massachusetts General Hospital
Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.EBI
Upjohn
Pepstatin analogues as novel renin inhibitors.EBI
TBA
Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.EBI
TBA
Direct renin inhibitors as a new therapy for hypertension.EBI
Novartis Pharmaceuticals
The P1N-isopropyl motif bearing hydroxyethylene dipeptide isostere analogues of aliskiren are in vitro potent inhibitors of the human aspartyl protease renin.EBI
Nagasaki International University
 
Novel low molecular renin inhibitors which show good oral blood pressure lowering effects in marmosetsEBI
TBA
 
CP-71,362, an unusually potent inhibitor of rat and dog reninEBI
TBA
 
Evaluation of the intestinal permeability and hepatic handling of peptidomimetic analogsEBI
TBA
 
MDL 74147, a novel selective and soluble inhibitor of human renin. Synthesis, structure-activity relationship, species and protease selectivities.EBI
TBA
The discovery of structurally novel CCR1 antagonists derived from a hydroxyethylene peptide isostere template.EBI
Pfizer
Studies directed toward the design of orally active renin inhibitors. 2. Development of the efficacious, bioavailable renin inhibitor (2S)-2-benzyl-3- [[(1-methylpiperazin-4-yl)sulfonyl]propionyl]-3-thiazol-4-yl-L-alanine amide of (2S,3R,4S)-2-amino-1-cyclohexyl-3,4-dihydroxy-6-methylheptane (A-725EBI
Abbott Laboratories
Renin inhibitors containing a pyridyl amino diol derived C-terminus.EBI
Hoechst
Nonpeptide renin inhibitors with good intraduodenal bioavailability and efficacy in dog.EBI
Abbott Laboratories
Renin inhibitors. Dipeptide analogues of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bond.EBI
Abbott Laboratories
Analysis of structure-activity relationships in renin substrate analogue inhibitory peptides.EBI
TBA
Synthesis and biological activity of some transition-state inhibitors of human renin.EBI
Ciba-Geigy
New human renin inhibitors containing an unnatural amino acid, norstatine.EBI
Kissei Pharmaceutical
Inhibitors of human renin. Cyclic peptide analogues containing a D-Phe-Lys-D-Trp sequence.EBI
Ici Pharmaceuticals Group
Potent renin inhibitory peptides containing hydrophilic end groups.EBI
Upjohn
Discovery of benzimidazole derivatives as orally active renin inhibitors: Optimization of 3,5-disubstituted piperidine to improve pharmacokinetic profile.EBI
Takeda Pharmaceutical
Renin inhibitory pentols showing improved enteral bioavailability.EBI
Hoechst